How Small Sponsors Can Best Access Clinical Trial Data with Lokavant’s Rohit Nambisan and Todd Johnson and MCC’s Linda Sullivan
How can small sponsors develop the right strategies to deal with the challenges of aggregating vital trial data? That’s one of the key topics explored during Linda Sullivan’s interview with Rohit Nambisan and Todd Johnson of Lokavant. The guests discuss the difficulties of getting needed data from outside vendors, standardizing the data and implementing the necessary analysis. Some smaller sponsors, the guests explain, historically have not realized the benefits of aggregated data, especially merging historical and ongoing trial data. That planning is far more complex that simply adding columns to a spreadsheet, and sponsors should focus their priorities on the highest possible use cases, the guests add. Finally, the guests say, small sponsors need to consider aggregating and standardizing data (“the new oil”) across multiple studies and CROs, and these sponsors need to negotiate access to this data in their contracts.